#contributionCompeting decay models tested side by side
Rather than asserting the endonucleolytic model, the study depletes CNOT1, PARN, EXOSC3/5/7, DDX17 and DHX30 and shows none affects HIV-CpG restriction or fragment abundance, while XRN1 depletion does. This converts a long-standing either/or in the literature into a testable and partly reconciled pathway.
↳ Figures S7B–S7G, 5C; Results §XRN1 degrades the 3′ fragment
#methodological rigourOrthogonal mapping of binding, cleavage and fragment fate
Triplicate iCLIP for both ZAP and KHNYN, long-read 5′ and 3′ RACE-seq, strand-specific p1/p2 primer-probe sets, and RNase-treated co-immunoprecipitations converge on the same pathway. Cleavage positions cluster inside independently called ZAP-binding peaks, and non-templated uridine tails appear only when ZAP is present.
↳ Figures 1I, 5A, 5G, 6B, 6D–6E
#methodological rigourEndogenous isoform editing avoids overexpression artefacts
Isoform comparison uses HEK293T cells CRISPR-engineered at the endogenous ZC3HAV1 locus so that only ZAP-L or only ZAP-S is expressed, directly addressing the criticism the paper levels at prior transient-transfection studies.
↳ Figures 1F–1I; Results §Differential antiviral activity between ZAP isoforms
#positioningTransparent reporting of shared panels and deposits
Figure legends disclose that input and pulldown blots are shared between Figures 3B/5E and 3C/S9I because the experiments were run together, antibodies carry catalogue numbers and RRIDs, and sequencing data and analysis code are deposited under named ArrayExpress accessions and Zenodo DOIs.
↳ Figure 3B and 3C legends; Key Resources Table; Data and code availability